Archive
A tighter archive for life-science signals.
Search once, then narrow by source or topic.
Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win - Fierce Pharma
Roche's Gazyva, on an autoimmune hot streak, looks to further its new foothold in lupus with phase 3 win Fierce Pharma
Directory ribbon
Brand directory, kept in view
A rolling strip of the companies, platforms, CROs and device makers that show up across the coverage.
Open about page